Targeting the EGFR pathway: An alternative strategy for the treatment of tuberous sclerosis complex?
Neuropathol Appl Neurobiol. 2024 Apr;50(2):e12974. doi: 10.1111/nan.12974. ABSTRACT INTRODUCTION: Tuberous sclerosis complex (TSC) is caused by variants in TSC1/TSC2, leading to constitutive activation of the …